PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 54 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $15,000 | -6.2% | 24,332 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $16,000 | +100.0% | 24,332 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $8,000 | -20.0% | 24,332 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $10,000 | -87.7% | 24,332 | -89.2% | 0.00% | -83.3% |
Q2 2016 | $81,000 | +710.0% | 224,332 | +822.0% | 0.01% | +500.0% |
Q1 2016 | $10,000 | – | 24,332 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 245,000 | $287,000 | 0.41% |
Iguana Healthcare Management, LLC | 500,000 | $585,000 | 0.19% |
Sterling Global Strategies LLC | 10,000 | $12,000 | 0.19% |
Delaney Dennis R | 60,000 | $70,000 | 0.16% |
Freedom Investment Management, Inc. | 816,347 | $955,000 | 0.07% |
BAXTER BROS INC | 135,506 | $159,000 | 0.06% |
First Heartland Consultants, Inc. | 86,204 | $101,000 | 0.04% |
TWO SIGMA SECURITIES, LLC | 16,191 | $19,000 | 0.02% |
CORRADO ADVISORS, LLC | 15,000 | $18,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 368,830 | $432,000 | 0.01% |